ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

Burzynski, Monaco Clashed In Court

June 5, 1992

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

Harkin, Hatfield Introduce Medical Research Trust Fund

March 4, 1994

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013